Recomendaciones de tamizaje de dengue en donante y receptor en trasplante de órganos sólidos
Palabras clave:
Dengue, Transplante de Órgãos, Doenças TransmissíveisResumen
El dengue, una infección caracterizada por ciclos epidémicos que se repiten cada 3 a 5 años, es uno de los problemas más destacados, dada su progresiva expansión en número de casos y extensión geográfica. A pesar de su amplia distribución geográfica, es en América y el sudeste asiático donde la enfermedad se presenta con mayor intensidad. Ante este escenario, el impacto potencial de esta epidemia en la población de receptores de trasplantes de órganos merece una consideración especial. Si bien se reconoce la escasez de datos sobre este tema en la literatura, se realizó una revisión de casos probables y confirmados de transmisión de dengue a través de donantes infectados, abordando las características clínicas y la evolución en los receptores de dichos órganos. Pensando en las estrategias adoptadas en otros países que ya han experimentado epidemias de dengue con transmisión del virus a través del trasplante de órganos, la Comisión de Infecciones de Trasplantes (COINT) de la Asociación Brasileña de Trasplantes (ABTO) describe el cribado de donantes y candidatos a trasplante con el uso combinado de NS1/IgM en sangre y criterios de aceptación de donantes y candidatos.
Descargas
Citas
World Health Organization [homepage na Internet]. Dengue – Global situation [atualizada em 21 Dez 2023; acesso em 28 Fev 2024]. Disponível em https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON498
Brasil. Ministério da Saúde do Brasil [homepage na Internet]. Painel de monitoramento de arboviroses [acesso em 14 Mar 2024]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/a/aedes-aegypti/monitoramento-dasarboviroses
Weerakkody RM, Patrick JA, Sheriff MH. Dengue fever in renal transplant patients: a systematic review of literature. BMC Nephrol 2017;18(1):15. https://doi.org/10.1186/s12882-016-0428-y
Brasil. Ministério da Saúde do Brasil. Dengue. Diagnóstico e manejo clínico. Adulto e criança. 6ª ed. Brasília (DF): Ministério da Saúde; 2024. [acesso em xx 18/03/2024. Disponível em http://bvsms.saude.gov.br/bvs/publicacoes/dengue_diagnostico_manejo_clinico_6ed.pdf
Di Ascia L, Jaffar-Bandjee MC, Cresta MP, Vasseur AS, Lugagne N, Vacher-Coponat H, et al. Dengue virus in kidney allograft: implications for donor screening and viral reservoir. Kidney Int Rep 2023;9(1):186-90. https://doi.org/10.1016/j.ekir.2023.10.012
Peghin M, Grossi PA. Donor-derived infections in solid organ transplant recipients. Curr Opin Organ Transplant 2023;28(5):384-90. https://doi.org/10.1111/j.1600-6143.2009.02889.x
Cedano JA, Mora BL, Parra-Lara LG, Manzano-Nuñez R, Rosso F. A scoping review of transmission of dengue virus from donors to recipients after solid organ transplantation. Trans R Soc Trop Med Hyg 2019;113(8):431-6. https://doi.org/10.1093/ trstmh/trz024
Brasil. Ministério da Saúde do Brasil. Dengue. Diagnóstico e manejo clínico. 6ª ed. Brasília (DF): Ministério da Saúde; 2024. [acesso em 18/03/2024]. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/dengue/dengue-diagnostico-e-manejo-clinico-adulto-e-crianca
Gonçalves BS, Horta MAP, Acero PHC, Bochner R, Queiroz Lima MDR, de Araújo ES, et al. Dynamics of nonstructural glycoprotein-1 in dengue patients presenting with different clinical manifestations from 1986 to 2012 in Rio de Janeiro, Brazil. J Med Virol 2019;91(4):555-63. https://doi.org/10.1002/jmv.25356
Duong V, Ly S, Try PL, Tuiskunen A, Ong S, Chroeung N, et al. Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl Trop Dis 2011;5(7):e1244. https://doi.org/10.1371/journal.pntd.0001244
Teoh BT, Sam SS, Tan KK, Johari J, Abd-Jamil J, Hooi PS, et al. The use of NS1 rapid diagnostic test and qRT-PCR to complement IgM ELISA for improved dengue diagnosis from single specimen. Sci Rep 2016;6:27663. https://doi.org/10.1038/srep27663
Wang SM, Sekaran SD. Early diagnosis of dengue infection using a commercial Dengue Duo rapid test kit for the detection of NS1, IGM, and IGG. Am J Trop Med Hyg 2010;83(3):690-5. https://doi.org/10.4269/ajtmh.2010.10-0117
Matos D, Tomashek KM, Perez-Padilla J, Muñoz-Jordán J, Hunsperger E, Horiuchi K, et al. Probable and possible transfusiontransmitted dengue associated with NS1 antigen-negative but RNA confirmed-positive red blood cells. Transfusion 2016;56(1):215-22. https://doi.org/10.1111/trf.13288
Humaidi M, Tien WP, Yap G, Chua CR, Ng LC. Non-invasive dengue diagnostics – The use of saliva and urine for different stages of the illness. Diagnostics (Basel) 2021;11(8):1345. https://doi.org/10.3390/diagnostics11081345
Andries AC, Duong V, Ly S, Cappelle J, Kim KS, Try PL, et al . Value of routine dengue diagnostic tests in urine and saliva specimens. PLoS Negl Trop Dis. 2015;9(9):e0004100. https://doi.org/10.1371/journal.pntd.0004100
Perera L, De Zoysa N, Jayarajah U, Senanayake N, De Zoysa I, Seneviratne SL. Transfusion-transmissible dengue infections. Trans R Soc Trop Med Hyg 2020;114(11):866-82. https://doi.org/10.1093/trstmh/traa075
Sabino EC, Loureiro P, Lopes ME, Capuani L, McClure C, Chowdhury D, et al. Transfusion-transmitted dengue and associated clinical symptoms during the 2012 epidemic in Brazil. J Infect Dis 2016;213(5):694-702. https://doi.org/10.1093/infdis/jiv326
Pozzetto B, Grard G, Durand G, Paty MC, Gallian P, Lucas-Samuel S, et al. Arboviral risk associated with solid organ and hematopoietic stem cell grafts: the prophylactic answers proposed by the French High Council of Public Health in a national context. Viruses 2023;15(9):1783. https://doi.org/10.3390/v15091783
Saigal S, Choudhary NS, Saraf N, Kataria S, Mohanka R, Soin AS. Transmission of dengue virus from a donor to a recipient after living donor liver transplantation. Liver Transpl 2013;19(12):1413-4. https://doi.org/10.1002/lt.23755
Gupta RK, Gupta G, Chorasiya VK, Bag P, Shandil R, Bhatia V, et al. Dengue virus transmission from living donor to recipient in liver transplantation: a case report. J Clin Exp Hepatol 2016;6(1):59-61. https://doi.org/10.1016/j.jceh.2016.01.005
Rosso F, Pineda JC, Sanz AM, Cedano JA, Caicedo LA. Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review. Braz J Infect Dis 2018;22(1):63-9. https://doi.org/10.1016/j. bjid.2018.01.001
Kumar S, Sable S, Yadav K, Sharma S, Chouhan A, Kapoor S, et al. Dengue transmission from donor to recipient after living donor liver transplant. Trop Gastroenterol 2019. https://dx.doi.org/10.7869/tg.497
Mathew JS, Menon VP, Menon VP, Mallick S, Amma BSPT, Balakrishnan D, et al. Dengue virus transmission from live donor liver graft. Am J Transplant 2019;19(6):1838-46. https://doi.org/10.1111/ajt.15270
Lecadieu A, Teysseyre L, Larsen K, Vidal C, Caron M, Traversier N, et al. Case report: transmission of dengue virus from a deceased donor to a kidney transplant recipient previously infected by dengue virus. Am J Trop Med Hyg 2021;104(6):2199-2201. https://doi.org/10.4269/ajtmh.21-0137
Sim JXY, Gan ES, Tan HC, Choy MM, Wong HM, Tan BH, et al. Aviremic organ transplant dengue virus transmission – A case report. Am J Transplant 2021;21(5):1944-7. https://doi.org/10.1111/ajt.16540
Jayant D, Behera A, Kaman L, Savlania A, Tandup C, Naik K. Dengue transmission from donor to recipient after deceased donor liver transplant; report of a case and review of literature: is liver a privileged organ? Exp Clin Transplant 2022;20(10):959-64. https://doi.org/10.6002/ect.2022.0136
Sociedade Brasileira de Imunizações. Nota Técnica Conjunta SBIm/SBI/SBMT - 03/07/2023 (atualizada em 06/03/2024). Vacina DENGUE 1,2,3 e 4 (atenuada) QDENGA®. [acesso em 15 Mar 2024]. Disponível em: https://sbim.org.br/images/files/notas-tecnicas/nota-tecnica-sbim-sbi-sbmt-qdenga-v5.pdf
Takeda. Dossiê de avaliação de tecnologias em saúde preparado para a CONITEC. QDENGA® (vacina dengue 1, 2, 3 e 4 – atenuada) indicada para a prevenção de dengue em indivíduos de 4 aos 60 anos de idade [acesso em 15 Mar 2024]. Disponível em: https://www.gov.br/conitec/pt br/midias/consultas/dossie/2023/DossietakedaVacinadengue.pdf
Bahakel H, Feldman AG, Danziger-Isakov L. Immunization of solid organ transplant candidates and recipients: a 2022 update. Infect Dis Clin North Am 2023;37(3):427-41. https://doi.org/10.1016/j.idc.2023.03.004
Danziger-Isakov L, Kumar D; AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: guidelines from the American Society of Transplantation infectious diseases community of practice. Clin Transplant 2019;33(9):e13563. Erratum in: Clin Transplant 2020;34(3):e13806. https://doi.org/10.1111/ctr.13563
Gould CV, Free RJ, Bhatnagar J, Soto RA, Royer TL, Maley WR, et al. Yellow fever vaccine virus transplant and transfusion investigation team. Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation. Lancet Microbe 2023;4(9):e711-21. Erratum in: Lancet Microbe . https://doi.org/10.1016/S2666-5247(23)00170-2
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Daniel Wagner de Castro Lima Santos , Raquel Silveira Bello Stucchi , Wanessa Trindade Clemente , Edson Abdala, Guilherme Santoro-Lopes, Ligia Pierrotti
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
